Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Eitemau Tebyg

• Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
  gan: Martin, Natasha K., et al.
  Cyhoeddwyd: (2016)
• Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
  gan: Martin, Natasha K., et al.
  Cyhoeddwyd: (2013)
• HCV Treatment as Prevention in People Who Inject Drugs – testing the evidence
  gan: Hickman, Matthew, et al.
  Cyhoeddwyd: (2015)
• Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
  gan: Grebely, Jason, et al.
  Cyhoeddwyd: (2017)
• The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
  gan: Stone, Jack, et al.
  Cyhoeddwyd: (2016)